(Total Views: 109)
Posted On: 11/12/2025 9:43:57 PM
Post# of 2786
2025 Q3 Filed November 12, 2025 - Key Points
Total Assets Value - September 30, 2025 vs December 31, 2024
$220,568,195 vs $19,968,195 - up $200,600,000 - up 1,005%
Total Current Assets Value - September 30, 2025 vs December 31, 2024
$14,502,453 vs $4,502,453 - up $10,000,000 - up 222%
Revenue - September 30, 2025 vs September 30, 2024
$1,771,375 vs $649,235 - up $1,122,140 - up 173%
Total Expenses - September 30, 2025 vs September 30, 2024
$269,949 vs $513,091 - down $243,142 - down 47%
Net Operating Gain - September 30, 2025 vs September 30, 2024
Profit $1,501,426 vs $136,144 - up $1,365,282 - up 1,003%
Total Assets Value - September 30, 2025 vs December 31, 2024
$220,568,195 vs $19,968,195 - up $200,600,000 - up 1,005%
Total Current Assets Value - September 30, 2025 vs December 31, 2024
$14,502,453 vs $4,502,453 - up $10,000,000 - up 222%
Revenue - September 30, 2025 vs September 30, 2024
$1,771,375 vs $649,235 - up $1,122,140 - up 173%
Total Expenses - September 30, 2025 vs September 30, 2024
$269,949 vs $513,091 - down $243,142 - down 47%
Net Operating Gain - September 30, 2025 vs September 30, 2024
Profit $1,501,426 vs $136,144 - up $1,365,282 - up 1,003%
(0)
(0)
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
